MedTrace Logo

Bright Light Therapy on Sleep Health in Lung Cancer Patients

NCT07064395 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-07-14

No results posted yet for this study

Summary

The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are:

* Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients?
* Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging.

Participants will:

* Receive bright light exposure or usual light exposure every day for 4 weeks
* Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests
* Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks
* Keep a daily sleep log

Conditions

Interventions

OTHER

bright light

Lung cancer patients in the bright light arm will receive 12,000 lux bright light through light visor for 4 weeks.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-09
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07064395 on ClinicalTrials.gov